Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - topiramate 200 mg - tablets - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - gabapentin 300 mg - capsules - gabapentin - - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy. - for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - flunitrazepam 2 mg - tablets - flunitrazepam - insomnia of various etiology.

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - sertraline as hydrochloride 50 mg - tablets - sertraline - for the treatment of symptoms of depression in patients with or without a history of mania. following satisfactory response, continuation with sertaline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - fluvoxamine maleate 50 mg - tablets - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - venlafaxine as hydrochloride 75 mg - capsules - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - montelukast as sodium 10 mg - tablets - montelukast - montelukast teva is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast teva is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

Izrael - arabščina - Ministry of Health

sanofi - aventis israel ltd - fexofenadine hydrochloride 180 mg - film coated tablets - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria.

Izrael - arabščina - Ministry of Health

salomon,levin & elstein ltd - loteprednol etabonate 5 mg / 1 ml - ophthalmic suspension - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

Izrael - arabščina - Ministry of Health

teva pharmaceutical indust.ltd - brimonidine tartrate 0.15 %w/v - ophthalmic solution - brimonidine - for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.